©2018 BY FERGUSON MITCHELL MARKETING 

RELIABLE, COMPREHENSIVE ANSWERS​

An easy, non-invasive blood test represents a major advance in prenatal testing delivering the answers you seek in just days. Med Labs prenatal testing is easy to order and needs only 1 tube of blood (just a 7mL sample). Simply ship the blood sample in its proprietary packaging to our CAP- accredited clinical lab. Our easy-to-read reports are available to the ordering physician via online portal, fax or mail, within just 2–4 business days.

​

Med Labs NIPT can also detect sex chromosome aneuploidies in singleton pregnancies—at no extra charge.  • Monosomy X (Turner syndrome)    • XXX (Triple X)     • XXY (Klinefelter syndrome)  • XYY (Jacobs syndrome)   • Fetal Sex (XX or XY) - aids in risk stratification of X-linked disorders such a hemophilia.

​

View Requisition >>

nIPT 

non-invasive prenatal

testing

CANDIDATES FOR NIPT 

Med Labs prenatal testing offers parents-to-be the option to obtain important information about the health of their developing baby, quickly, accurately and with little to no risk to their pregnancy.

This screening test is usually indicated for pregnant women who meet any of the following criteria:

AGE 35 YEARS OLD OR OLDER

Patient is considered to be of advanced maternal age at time of delivery

​

SCREENING ABNORMALITIES

Patient ultrasound shows concerns or abnormalities with fetal growth and/or development. Or  patient has an abnormal or “positive” serum screen

Patient has a personal or family history suggestive of trisomies 21, 18, 13, or other sex chromosome aneuploidies

FAMILY HISTORY

OPTIMIZED APPROACH TO GENETIC SEQUENCING

Med Labs prenatal testing leverages the power of Massively Parallel Sequencing (MPS) across the whole genome. The industry’s deepest sequencing approach combined with a highly optimized algorithm provides a clearer, more reliable answer than other methods. Shallower sequencing necessitates using fetal fraction (ff) estimates as compensation for weaker sequencing power. Without using ff estimates, the incidence of false negatives would be clinically unacceptable and result in higher numbers of sample rejections and delayed result time. Utilizing the power of deeper sequencing, Med Labs testing gives reassurance by:

• Eliminating unnecessary sample rejections • Reducing the need for redraws • Obviating requests for paternal samples • Providing fast time to report (2–4 business days)